BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 108 filers reported holding BIOXCEL THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $43,849 | -74.0% | 34,257 | -40.0% | 0.00% | – |
| Q4 2023 | $168,398 | -41.1% | 57,084 | +504.8% | 0.00% | -100.0% |
| Q3 2021 | $286,000 | -68.6% | 9,438 | -69.9% | 0.00% | -66.7% |
| Q2 2021 | $911,000 | +90.2% | 31,351 | +202.5% | 0.00% | -25.0% |
| Q4 2020 | $479,000 | +48.8% | 10,365 | -28.1% | 0.00% | -50.0% |
| Q1 2020 | $322,000 | -4.7% | 14,419 | -37.6% | 0.01% | +300.0% |
| Q4 2019 | $338,000 | +35.2% | 23,118 | -35.0% | 0.00% | 0.0% |
| Q3 2019 | $250,000 | -29.0% | 35,548 | +10.5% | 0.00% | -33.3% |
| Q2 2019 | $352,000 | +147.9% | 32,162 | +73.8% | 0.00% | +50.0% |
| Q3 2018 | $142,000 | – | 18,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 430,000 | $19,866,000 | 1.70% |
| APIS CAPITAL ADVISORS, LLC | 20,000 | $924,000 | 0.89% |
| Avidity Partners Management LP | 547,000 | $25,271,000 | 0.82% |
| Knoll Capital Management, LLC | 20,000 | $924,000 | 0.63% |
| Artemis Investment Management LLP | 1,013,448 | $46,839,000 | 0.49% |
| AlphaCentric Advisors LLC | 25,000 | $1,155,000 | 0.48% |
| First Light Asset Management, LLC | 94,202 | $4,352,000 | 0.32% |
| Ikarian Capital, LLC | 150,000 | $6,930,000 | 0.31% |
| Longitude (Cayman) Ltd. | 8,000 | $370,000 | 0.18% |
| AllSquare Wealth Management LLC | 5,490 | $254,000 | 0.17% |